Table 3 Distributions of alleles and genotypes between T2DM patients and control subjects in males
Polymorphism | T2DM | Non-diabetic | Unadjusted Pa | Adjusted OR(95% CI)/Pb |
|---|---|---|---|---|
rs3806318 | n = 363 | n = 393 |  |  |
 AA | 287(79.1%) | 302(76.9%) | 0.756 | 1 |
 AG | 73(20.1%) | 87(22.1%) |  | 1.020(0.439–2.370)/0.964 |
 GG | 3(0.8%) | 4(1.0%) |  | 0.880(0.404–1.915)/0.747 |
 A | 647(89.1%) | 691(87.9%) | 0.463 | 1 |
 G | 79(10.9%) | 95(12.1%) |  | 0.894(0.639–1.251)/0.514 |
rs1327118 | n = 361 | n = 390 |  |  |
 CC | 293(81.2%) | 300(76.9%) | 0.252 | 1 |
 CG | 65(18.0%) | 83(21.3%) |  | 1.491(0.628–3.541)/0.365 |
 GG | 3(0.8%) | 7(1.8%) |  | 0.512(0.230–1.136)/0.100 |
 C | 651(90.2%) | 683(87.6%) | 0.110 | 1 |
 G | 71(9.8%) | 97(12.4%) |  | 0.707(0.504–0.991)/0.044 |